SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001739614-23-000035
Filing Date
2023-04-13
Accepted
2023-04-13 16:05:05
Documents
8
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A inbx2023proxy.htm DEF 14A 498123
2 chart-b713dde3c9434b4194e.jpg GRAPHIC 83283
3 chart-f7cf237088e24a158b1.jpg GRAPHIC 83308
4 graphicboardrec.jpg GRAPHIC 1396
5 graphiccontrolnumberbox.jpg GRAPHIC 2205
6 graphicsignature.jpg GRAPHIC 30818
7 graphicvoting.jpg GRAPHIC 80631
8 inbxlogo.jpg GRAPHIC 5120
  Complete submission text file 0001739614-23-000035.txt   894917
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39452 | Film No.: 23818388
SIC: 2836 Biological Products, (No Diagnostic Substances)